BIT
NEOS

BlackRock Institutional Trust’s Neos Therapeutics, Inc NEOS Stock Holding History

BlackRock Institutional Trust’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.19M Buy
202,813
+31,659
+18% +$214K ﹤0.01% 3243
2016
Q3 		$1.13M Sell
171,154
-1,382
-0.8% -$10.9K ﹤0.01% 3248
2016
Q2 		$1.6M Buy
172,536
+59,533
+53% +$568K ﹤0.01% 3124
2016
Q1 		$1.22M Sell
113,003
-1,108
-1% -$11.7K ﹤0.01% 3230
2015
Q4 		$1.63M Buy
114,111
+9,721
+9% +$147K ﹤0.01% 3192
2015
Q3 		$2.19M Buy
+104,390
New +$2.3M ﹤0.01% 3088

Other funds holding NEOS

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock Institutional Trust's NEOS Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Neos Therapeutics, Inc (NEOS) stake by 18% in Q4 2016, buying an estimated $214K and bringing the position to 202,813 shares worth $1.19M. The position accounts for ﹤0.01% of the portfolio, ranked #3243.

BlackRock Institutional Trust first reported a position in NEOS in Q3 2015 and has held it in 6 quarters since. The position peaked at $2.19M in Q3 2015. 52 funds tracked by Wall St. Rank hold NEOS as of Q4 2016.

  • BlackRock Institutional Trust held 202,813 shares of Neos Therapeutics, Inc worth $1.19M as of Q4 2016.
  • BlackRock Institutional Trust bought 31,659 Neos Therapeutics, Inc shares in Q4 2016, an estimated $214K.
  • Neos Therapeutics, Inc made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3243 holding.
  • BlackRock Institutional Trust first reported a position in Neos Therapeutics, Inc in Q3 2015 and has held it in 6 quarters since.
  • BlackRock Institutional Trust's Neos Therapeutics, Inc position peaked at $2.19M in Q3 2015.
  • 52 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.